OM
PT Jayamas Medica Industri Tbk
OMED.JK · JKT
Rp 220.00 -0.90% (-Rp 2.00)
1M -3.48%
Market Cap Rp 6.21T
P/E Ratio 14.36x
Div. Yield 1.77%
ROE 15.76%
Bulios Fair Price
Rp 121.19
44.9% downside
Current Price
Rp 220
Undervalued Fair Value Overvalued
According to Bulios Fair Price, OMED.JK is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
72 /100
Cheap P/FCF 25.35x
P/S 2.70x
P/B 2.20x
Growth
67 /100
Growing Rev. growth 5.87%
FCF growth 152.97%
Book val. growth 9.99%
Profitability
78 /100
Strong Net margin 18.77%
Op. margin 19.66%
FCF margin 10.63%
Quality
71 /100
Excellent ROE 15.76%
ROA 12.68%
Asset turnover 0.68x
Debt
100 /100
Low Current ratio 8.29x
Int. coverage 19.38x
Net debt/EBITDA -1.80x
Stability
90 /100
Stable Rev. volatility 5.28%
EPS volatility 17.03%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about OMED.JK
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Herlien Sri Ariani
Employees
1,340
Headquarters
Sidoarjo